Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms.

Scientific reports - 27 Dec 2019

Belcic Mikic Tanja, Pajic Tadej, Sever Matjaz

Abstract excerpt

Suspicion of myeloproliferative neoplasms (MPNs) and especially essential thrombocythemia (ET) in primary care is often based solely on blood counts, with patients referred to a haematologist without a thorough evaluation. We retrospectively assessed the role of calreticulin gene (CALR) mutations in the diagnosis of MPN in this population. We studied CALR mutations in 524 JAK2 V617F-negative patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calreticulin
Share to Genetic Testing
Share to Hematologic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Share to Thrombocythemia, Essential

Source

Open in PubMed Open full text

Identifiers

PMID: 31882869
DOI: 10.1038/s41598-019-56236-x
PMCID: PMC6934448

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms.PMID 31882869Read ↗

The prevalence of CALR mutations in a cohort of patients with myeloproliferative neoplasms.Semantic proximity Read ↗

Calreticulin Mutations in Myeloproliferative NeoplasmsSemantic proximity Read ↗

Frequency and Molecular Characteristics of Calreticulin Gene (CALR) Mutations in Patients with JAK2-Negative Myeloproliferative NeoplasmsSemantic proximity Read ↗

The characteristics of CALR mutations in myeloproliferative neoplasms: a clinical experience from a tertiary care center in Qatar and a literature review.Semantic proximity Read ↗

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms.Semantic proximity Read ↗

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.Semantic proximity Read ↗

Calreticulin exon 9 mutations in myeloproliferative neoplasms.Semantic proximity Read ↗

Calreticulin Immunohistochemistry in Myeloproliferative Neoplasms - Evolution of a New Cost-Effective Diagnostic Tool: A Retrospective Study with Histological and Molecular Correlation.Semantic proximity Read ↗

Calreticulin Type 26 Mutation in Myelofibrosis: A Rare Variant With Diagnostic Challenges.Semantic proximity Read ↗

Mutations in MPNs: prognostic implications, window to biology, and impact on treatment decisionsSemantic proximity Read ↗

Mutant Calreticulin in the Myeloproliferative NeoplasmsSemantic proximity Read ↗

Calreticulin mutations in essential thrombocythemia and primary myelofibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.